GLOBUS MED INC's ticker is GMED and the CUSIP is 379577208. A total of 262 filers reported holding GLOBUS MED INC in Q2 2019. The put-call ratio across all filers is 4.26 and the average weighting 0.2%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q3 2019 | $425,000 | +16.1% | 8,308 | -4.0% | 0.03% | +39.1% |
| Q2 2019 | $366,000 | -29.6% | 8,658 | -17.8% | 0.02% | -39.5% |
| Q1 2019 | $520,000 | +5.9% | 10,529 | -7.1% | 0.04% | -5.0% |
| Q4 2018 | $491,000 | +0.6% | 11,338 | +31.9% | 0.04% | +29.0% |
| Q3 2018 | $488,000 | +43.1% | 8,593 | +27.2% | 0.03% | +40.9% |
| Q2 2018 | $341,000 | +39.2% | 6,758 | +37.4% | 0.02% | +57.1% |
| Q1 2018 | $245,000 | +2127.3% | 4,920 | +1347.1% | 0.01% | – |
| Q2 2017 | $11,000 | -99.9% | 340 | -99.9% | 0.00% | -100.0% |
| Q2 2016 | $7,422,000 | +0.3% | 311,460 | -0.0% | 0.36% | +0.6% |
| Q1 2016 | $7,399,000 | -14.7% | 311,545 | -0.1% | 0.36% | -11.2% |
| Q4 2015 | $8,674,000 | +19.3% | 311,792 | -11.4% | 0.40% | +13.6% |
| Q3 2015 | $7,270,000 | +75.1% | 351,903 | +117.6% | 0.35% | +98.9% |
| Q2 2015 | $4,151,000 | -20.7% | 161,722 | -26.1% | 0.18% | -17.2% |
| Q2 2014 | $5,236,000 | – | 218,884 | – | 0.22% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| Sterling Investment Advisors, Ltd. | 277,723 | $14,197,000 | 7.25% |
| Consonance Capital Management LP | 1,313,177 | $67,130,000 | 6.64% |
| PARADIGM CAPITAL MANAGEMENT INC/NY | 938,900 | $47,997,000 | 4.30% |
| Next Capital Management LLC | 111,098 | $5,679,000 | 3.81% |
| Godshalk Welsh Capital Management, Inc. | 83,305 | $4,259,000 | 3.76% |
| Global Alpha Capital Management Ltd. | 317,650 | $16,238,000 | 2.81% |
| Pembroke Management, LTD | 369,575 | $18,893,000 | 2.06% |
| Van Berkom & Associates Inc. | 1,528,936 | $78,159,000 | 1.92% |
| NUANCE INVESTMENTS, LLC | 865,872 | $44,263,000 | 1.67% |
| Bridge City Capital, LLC | 57,031 | $2,915,000 | 1.26% |